Generics Products found!

Innovative

Biosimilars

Medical devices

Nutraceuticals

Filters

Saxagliptin manufacturers

Filters

None products found

saxagliptin + metformin

Tablets 2.5 mg + 500 mg, 2.5 mg + 1000 mg, 5 mg + 500 mg, 5 mg + 1000 mg

Dossier type
CTD
Dossier status
Ready to file
Country of origin
India
GMP approvals
FDA, EU GMP, ANVISA, WHO
Comments
Innovator Brand: Kombiglyze XR
Manufacturer #18119
This company is a leading global manufacturer of Active Pharmaceutical Ingredients (APIs) with USFDA approved facilities recognized by international regulatory bodies. They are known for their robust research and development, focusing on anti-diabetic, antidepressant, and anticoagulant therapies. They boast over 25 new molecules in advanced stages of development with strong intellectual property protections.The company offers a wide range of finished formulations, including generic medicines for multispecialty, cardiac, and diabetic categories. They also have a significant presence in the OTC market with over 400 products, led by well-established brands like Burnol. Their home diagnostics product line includes blood glucose monitors, BP monitors, nebulizers, thermometers, weighing scales, and steamers. They export to over 80 countries and hold certifications such as USFDA, WHO GMP, and EU GMP.

Manufacturer usually replies in 89 days

saxagliptin

Tablets 2.5 mg, 5 mg

Dossier type
CTD
Dossier status
Ready to file
Country of origin
India
GMP approvals
WHO
Manufacturer #3825

Established in 1994, this GMP manufacturer specializes in the development and production of CTD dossiers. As a CTD dossier owner and manufacturer, it ensures quality compliance across various markets. With GMP approvals, it showcases commitment to high standards. The manufacturer operates multiple production lines designed for diverse pharmaceutical formulations, catering to a wide range of needs. Its products are sold in over 25 countries and regions worldwide, supported by a dedicated team of around 300 employees. This GMP manufacturer excels as a CTD dossier owner and manufacturer, meeting global regulatory requirements efficiently.

Manufacturer usually replies in 45 days

saxagliptin

Tablets 2.5 mg, 5 mg

Dossier type
CTD
Dossier status
Ready to file
Country of origin
Pakistan
GMP approvals
WHO, Nigeria, Pakistan, Kenya, Uganda, Ghana, Ivory Coast
Manufacturer #21095

This CTD dossier owner and manufacturer specializes in manufacturing a wide range of medications and healthcare products across various therapeutic areas, including anti-infectives, cardiometabolics, gastroenterology, neurology, obstetrics & gynecology, ophthalmology, orthopedics, pediatrics, respiratory care, and urology. They produce both prescription medications and over-the-counter drugs in diverse dosage forms, adhering to strict Good Manufacturing Practices (GMP) certifications and local/international standards. Key production lines include sterile products and non-sterile formulations. The company boasts a strong track record, recognized with multiple awards for export excellence and quality assurance. Their global reach extends to the EU and North America, demonstrating their commitment to serving international healthcare needs.

Manufacturer usually replies in 26 days

Want to see all products?

Subscribe today to benefit from:

  • Streamlined product sourcing - the leading CTD dossiers database focused on finished dosage formulations

  • Direct negotiations - connect and negotiate directly with manufacturers without any brokerage fee

  • Increased profitability - secure the best commercial terms for your business by comparing offers from several manufacturers

Request Subscription

Saxagliptin

Saxagliptin is used to lower blood sugar levels in patients with type 2 diabetes. Saxagliptin is called a dipeptidyl peptidase-4 (DPP-4) inhibitor. Amongst people with type-2 diabetes and high blood sugar tend to develop serious or life-threatening complications. These complications impact the healthy functioning of vital organs causing heart disease, stroke, kidney problems, nerve damage, and eye problems. Saxagliptin therapy decreases the risk of probability of a heart attack, stroke, and other types 2 related complications affecting kidney failure, nerve damage, eye problems, including changes or loss of vision, or gum disease. patients suffering from type 2 diabetes are not able to produce enough insulin, Saxagliptin works by increasing the amount of insulin produced by the body after meals. Saxagliptin, sold under the brand name Onglyza amongst others. The incidence of type 2 diabetes has increased significantly since 1960 as a function of obesity. Even in 2015, Approximately 392 million people were diagnosed with it compared to 30 million in only 30 years ago. Although it mostly affects people in their middle or older age, rates of type 2 diabetes are increasing in young people. It is known the reduce life expectancy by 10 years. Bristol-Myers Squibb conducted the early development, later in 2007, AstraZeneca joined with Bristol-Myers Squibb to co-develop the final compound and marketing of the drug. The FDA approved saxagliptin with the brand name Onglyza in 2009. The European Medicines Agency In 2006 licensed Saxagliptin for use throughout the European Union, Bristol-Myers Squibb announced that Otsuka Pharmaceutical Co has been granted exclusive rights to develop and commercialize the compound in Japan.

Dosage Forms & Strengths

Saxagliptin is sold in a tablet of 2.5mg and 5mg strength. In the treatment of Diabetes Mellitus Type 2 the patients are recommended a dose of 2.5-5 mg daily.

The cost of Saxagliptin

In the USA, a consumer has to pay approximately $203 for the 2.5- or 5.0-mg tablets for a month’s supply. In the UK, the 2.5mg tablets cost 32 pounds for a supply of 28 pills.

How does Saxagliptin work?

Saxagliptin actions increase the amount of insulin produced after meals when blood sugar is high. Saxagliptin is from a class of medications called dipeptidyl peptidase-4 (DPP-4) inhibitor antidiabetic. DPP-4 inhibitors work by affecting the action of natural hormones in the body called Incretins. These Incretins are responsible for decreased blood sugar by increasing the consumption of sugar by the body, mainly through increasing insulin production in the pancreas. It also signals the liver to stop producing sugar when there is too much sugar in the blood and by reducing the production of sugar by the liver.

Finding Saxagliptin Manufacturers and Saxagliptin Suppliers

One of the fastest and easiest ways to find Saxagliptin manufacturers and Saxagliptin suppliers is to make use of Pipelinepharma's global B2B online marketplace for medicines and other pharmaceuticals. Usually, finding trusted manufacturers and supplies of specific drugs like Saxagliptin can be a time-consuming challenge, but with Pipelinepharma's simple search engine and network of proven partners, the whole process becomes a lot easier. All you need to do to get started is make use of our integrated search engine and start looking for suppliers or manufacturers of Saxagliptin to work with. You can fine-tune your search results using various filters too, letting you search for Saxagliptin from specific countries, for example. Onglyza, Qternmet XR, Qtern, Kombiglyze XR https://www.drugs.com/ingredient/saxagliptin.html https://medlineplus.gov/druginfo/meds/a610003.html https://en.wikipedia.org/wiki/Saxagliptin https://www.drugbank.ca/drugs/DB06335 https://reference.medscape.com/drug/onglyza-saxagliptin-999211

Interested in Subscription?

Please fill out form and send us your specific requirements, and we will get back to you as soon as possible

Want unlimited access to the Pipelinepharma database?

Become a subscriber to unlock:

  • Streamlined product sourcing: access the only CTD dossier pipeline and sourcing platform.

  • Direct connections: communicate directly with CTD dossier owners and manufacturers with no brokerage fees.

  • Higher profitability: compare multiple supplier offers and secure the best commercial terms.

  • Expanded network: view supplier portfolios and stay updated on new products.

  • Value-added product ideas: discover products with lower competition potential.

  • Access to marketing authorizations for sale: find already registered products in your target markets.